Homologous Tumor Cell-Derived Biomimetic Nano-Trojan Horse Integrating Chemotherapy with Genetherapy for Boosting Triple-Negative Breast Cancer Therapy
ACS Applied Materials & Interfaces · 2024
DOI: 10.1021/acsami.4c08842 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2024. Verfasst von Wenjie Duan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Jiangsu Cancer Hospital, the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Institute of Cancer Research, …. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Doxorubicin, Nanoparticles, MicroRNAs. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Excellent Postdoctoral Program of Jiangsu Province, National Health Council Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Jiangsu Cancer Hospital, the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Institute of Cancer Research, 42 Baiziting Road, Nanjing 210009, China.
- Key Laboratory of Flexible Electronics (KLOFE), School of Flexible Electronics (Future Technologies) & Institute of Advanced Materials (IAM), Nanjing Tech University (NanjingTech), 30 South Puzhu Road, Nanjing 211816, C…
ORCID-Profile: Changmin Yu, Jifu Wei
Förderung
- National Key Research and Development Program of China
- Excellent Postdoctoral Program of Jiangsu Province
- National Health Council Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine
Zitieren
APA
Duan, W., Shen, Q., Ju, L., Huang, Z., Geng, J., Wu, Q., Yu, C., & Wei, J. (2024). Homologous Tumor Cell-Derived Biomimetic Nano-Trojan Horse Integrating Chemotherapy with Genetherapy for Boosting Triple-Negative Breast Cancer Therapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c08842
Vancouver
Duan W, Shen Q, Ju L, Huang Z, Geng J, Wu Q, et al. Homologous Tumor Cell-Derived Biomimetic Nano-Trojan Horse Integrating Chemotherapy with Genetherapy for Boosting Triple-Negative Breast Cancer Therapy. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c08842
BibTeX
@article{Duan2024,
author = {Duan, Wenjie and Shen, Qian and Ju, Linjie and Huang, Zhongxi and Geng, Jiaying and Wu, Qiong and Yu, Changmin and Wei, Jifu},
title = {Homologous Tumor Cell-Derived Biomimetic Nano-Trojan Horse Integrating Chemotherapy with Genetherapy for Boosting Triple-Negative Breast Cancer Therapy},
journal = {ACS Applied Materials & Interfaces},
year = {2024},
doi = {10.1021/acsami.4c08842}
}
EUVIMED